Angela de Haan

Dr. Angela de Haan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2021 in Microbial Genomics
Verified
Journal Article
Open access
AHAntoni P.A. P.A. Hendrickx
Antoni P.A. P.A. Hendrickx
FLFabian Landman
Fabian Landman
AHAngela de Haan
Angela de Haan
SWSandra Witteveen
Sandra Witteveen
MSMarga G van Santen-Verheuvel
Marga G van Santen-Verheuvel
LSLeo Schouls
Leo Schouls
Carbapenem-hydrolysing enzymes belonging to the OXA-48-like group are encoded by bla OXA-48-like alleles and are abundant among Enterobacterales in the Netherlands. Therefore, the objective here was to investigate the characteristics, gene content and diversity of the bla OXA-48-like carrying plasmids and chromosomes of Escherichia coli and Klebsiella pneumoniae collected in the Dutch national surveillance from 2014 to 2019 in comparison with genome sequences from 29 countries. A combination of short-read genome sequencing with long-read sequencing enabled the reconstruction of 47 and 132 complete bla OXA-48-like plasmids for E. coli and K. pneumoniae , respectively. Seven distinct plasmid groups designated as pOXA-48-1 to pOXA-48-5, pOXA-181 and pOXA-232 were identified in the Netherlands which were similar to internationally reported plasmids obtained from countries from North and South America, Europe, Asia and Oceania. The seven plasmid groups varied in size, G+C content, presence of antibiotic resistance genes, replicon family and gene content. The pOXA-48-1 to pOXA-48-5 plasmids were variable, and the pOXA-181 and pOXA-232 plasmids were conserved. The pOXA-48-1, pOXA-48-2, pOXA-48-3 and pOXA-48-5 groups contained a putative conjugation system, but this was absent in the pOXA-48-4, pOXA-181 and pOXA-232 plasmid groups. pOXA-48 plasmids contained the PemI antitoxin, while the pOXA-181 and pOXA-232 plasmids did not. Furthermore, the pOXA-181 plasmids carried a virB2-virB3-virB9-virB10-virB11 type IV secretion system, while the pOXA-48 plasmids and pOXA-232 lacked this system. A group of non-related pOXA-48 plasmids from the Netherlands contained different resistance genes, non-IncL-type replicons or no replicons. Whole genome multilocus sequence typing revealed that the bla OXA-48-like plasmids were found in a wide variety of genetic backgrounds in contrast to chromosomally encoded bla OXA-48-like alleles. Chromosomally localized bla OXA-48 and bla OXA-244 alleles were located on genetic elements of variable sizes and comprised regions of pOXA-48 plasmids. The bla OXA-48-like genetic element was flanked by a direct repeat upstream of IS1R, and was found at multiple locations in the chromosomes of E. coli . Lastly, K. pneumoniae isolates carrying bla OXA-48 or bla OXA-232 were mostly resistant for meropenem, whereas E. coli bla OXA-48, bla OXA-181 and chromosomal bla OXA-48 or bla OXA-244 isolates were mostly sensitive. In conclusion, the overall bla OXA-48-like plasmid population in the Netherlands is conserved and similar to that reported for other countries, confirming global dissemination of bla OXA-48-like plasmids. Variations in size, presence of antibiotic resistance genes and gene content impacted pOXA-48, pOXA-181 and pOXA-232 plasmid architecture.

15 December 2022 in Eurosurveillance
Verified
Journal Article
Open access
RZRomy Zwittink
Romy Zwittink
CWCornelia Christina Henrica Wielders
Cornelia Christina Henrica Wielders
DNDaan W Notermans
Daan W Notermans
NVNelianne J. Verkaik
Nelianne J. Verkaik
ASAnnelot F Schoffelen
Annelot F Schoffelen
MGMRSA Surveillance Study Groups
MRSA Surveillance Study Groups
Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

1 October 2020 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
KZK. van der Zwaluw
K. van der Zwaluw
SWS. Witteveen
S. Witteveen
LWL. Wielders
L. Wielders
MSM. van Santen
M. van Santen
FLF. Landman
F. Landman
MWM.J.H.M. Wolfhagen
M.J.H.M. Wolfhagen
Carbapenem resistance mediated by mobile genetic elements has emerged worldwide and has become a major public health threat. To gain insight into the molecular epidemiology of carbapenem resistance in The Netherlands, Dutch medical microbiology laboratories are requested to submit suspected carbapenemase-producing Enterobacterales (CPE) to the National Institute for Public Health and the Environment as part of a national surveillance system. Meropenem MICs and species identification were confirmed by E-test and MALDI-TOF and carbapenemase production was assessed by the Carbapenem Inactivation Method. Of all submitted CPE, one species/carbapenemase gene combination per person per year was subjected to next-generation sequencing (NGS). In total, 1838 unique isolates were received between 2014 and 2018, of which 892 were unique CPE isolates with NGS data available. The predominant CPE species were Klebsiella pneumoniae (n = 388, 43%), Escherichia coli (n = 264, 30%) and Enterobacter cloacae complex (n = 116, 13%). Various carbapenemase alleles of the same carbapenemase gene resulted in different susceptibilities to meropenem and this effect varied between species. Analyses of NGS data showed variation of prevalence of carbapenemase alleles over time with blaOXA-48 being predominant (38%, 336/892), followed by blaNDM-1 (16%, 145/892). For the first time in the Netherlands, blaOXA-181, blaOXA-232 and blaVIM-4 were detected. The genetic background of K. pneumoniae and E. coli isolates was highly diverse. The CPE population in the Netherlands is diverse, suggesting multiple introductions. The predominant carbapenemase alleles are blaOXA-48 and blaNDM-1. There was a clear association between species, carbapenemase allele and susceptibility to meropenem.

5 November 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
NVNelianne J. Verkaik
Nelianne J. Verkaik
CWCornelia Christina Henrica Wielders
Cornelia Christina Henrica Wielders
HBHans Den Boer
Hans Den Boer
DLDiana Langerak
Diana Langerak
MVMarius Vogel
Marius Vogel
ORon behalf of the SWAB Working Group Surveillance of Antimicrobial Resistance
on behalf of the SWAB Working Group Surveillance of Antimicrobial Resistance
Since March 2022, an increase was observed in multidrug-resistant microorganisms (MDRO), associated with the hospital transfer of Ukrainian patients. The goal was to collect phenotypic susceptibility data and assess clinical implications. Carbapenemase-producing Enterobacterales (CPE, n = 96), Pseudomonas aeruginosa (CPPA, n = 20), and carbapenem-resistant Acinetobacter baumannii–calcoaceticus (CRAB, n = 6) from Ukrainian patients were obtained from March to December 2022 from the Dutch MDRO surveillance. Antimicrobial susceptibility testing was performed using broth microdilution (BMD) when available, fosfomycin agar dilution, disk diffusion (DD) for cefiderocol, and diverse gradient strips. All isolates were sequenced with Illumina next-generation sequencing. For meropenem, aminoglycosides, ceftazidime–avibactam, ceftolozane–tazobactam, and imipenem–relebactam, susceptibility rates were low (0%–30%), due to the high number of bla NDM -positive isolates (79/122; 65%). For cefiderocol, results depended on reading with or without microcolonies, applying EUCAST or CLSI breakpoints, and whether DD or BMD was used; e.g., for Klebsiella pneumoniae , 30%–97% were susceptible. For colistin, 103/111 (93%) non-intrinsically resistant CPE/CPPA/CRAB isolates were susceptible. For most CPE, a low minimal inhibitory concentration (MIC) of <0.5 mg/L was measured for tigecycline and ceftazidime–avibactam–aztreonam. For CPPA, cefiderocol tested susceptible in 65%–100% of isolates. For CRAB, ampicillin–sulbactam MICs were ≥128 mg/L; for sulbactam–durlobactam, 1–2 mg/L. Admission in a Ukrainian hospital in the last year was a risk factor for MDRO, and majority were screening isolates (79%). There is extensive phenotypic resistance to last-resort antibiotics in MDRO from Ukrainian patients. Interpretation of cefiderocol susceptibility results depends on several variables. When treating patients recently admitted in Ukraine, suspected for Gram-negative bacterial infection, this should be taken into consideration. IMPORTANCE: Since March 2022, multidrug-resistant microorganisms associated with Ukrainian patients have been detected in national surveillance systems of several European countries. We studied the phenotypic antimicrobial susceptibility to last-resort antibiotics of multidrug-resistant microorganisms from Ukrainian patients in the Netherlands and assessed clinical implications. Our research revealed that there was extensive phenotypic resistance to last-resort antibiotics. Healthcare professionals should be aware of multidrug-resistant microorganisms when treating patients recently admitted in Ukraine, suspected for Gram-negative bacterial infection.

7 April 2026 in Microbiology Spectrum
Verified
Journal Article
Open access
MAMax P. Allewijn
Max P. Allewijn
SWSandra Witteveen
Sandra Witteveen
KVKaruna E. W. Vendrik
Karuna E. W. Vendrik
AHAngela de Haan
Angela de Haan
FLFabian Landman
Fabian Landman
AHAntoni P.A. P.A. Hendrickx
Antoni P.A. P.A. Hendrickx
We investigated the genomic epidemiology of carbapenem-resistant Acinetobacter baumannii (CRAb) during two surveillance periods: 2015–2017 (pilot 1) and 2022–2024 (pilot 2) in an international context to identify potential circulating high-risk lineages in the Netherlands. A total of 204 CRAb isolates were all analyzed by the carbapenem inactivation method, meropenem Etest, and whole-genome sequencing (combining Illumina and Nanopore). Comparative resistome, multilocus sequence typing (MLST), and whole-genome MLST (wgMLST) analyses were performed between pilots and compared to 577 international CRAb genomes. The Dutch CRAb population remained genetically diverse and stable between pilots and was dominated by international clone (IC)2 (61.8%), followed by IC9 (11.3%), IC1 (6.4%), and IC6 (5.9%). Also, epidemiological and clinical characteristics remained stable across both pilots. In contrast, CRAb in patients from Ukraine was genetically diverse and an epidemiologically distinct group. wgMLST indicated an increase in genetic clustering in 2022–2024, with unique CRAb clusters associated with Ukrainian patients. Of 26 identified clusters, 69% were linked to international sources. Differences in resistomes were observed between CRAb in patients from the Netherlands and Ukraine, and between pilots. Overall, 75% of isolates harbored bla OXA-23 -like genes, and bla NDM genes increased from 16% to 21%. None of the CRAb isolates from Ukrainian patients carried bla NDM genes; instead, they harbored bla OXA-23 -like and bla OXA-24 -like genes. Hybrid assemblies showed that carbapenemase genes were predominantly chromosomal. In conclusion, CRAb in the Netherlands showed genetic stability over time, yet the presence of New Delhi metallo-β-lactamase-carbapenemases and import of strains from high-risk regions underline the necessity for ongoing national surveillance. IMPORTANCE: In 2015–2017 and 2022–2024, pilot surveillance of carbapenem-resistant Acinetobacter baumannii (CRAb) was performed in the Netherlands. Three distinct groups were compared based on epidemiological and genomic data: CRAb from 2015 to 2017 and for the 2022–2024 period, CRAb in patients from the Netherlands, and CRAb in patients from Ukraine in the Netherlands. The genomic epidemiology of CRAb has been mostly stable between 2015–2017 and 2022–2024 but seems to be strongly affected by the introduction of CRAb from foreign countries. A proportion of the 2022–2024 isolates were from Ukrainian patients. The resistance genes of CRAb from Ukrainian patients were different from those of the Netherlands. CRAb in the Netherlands are acquiring New Delhi metallo-β-lactamase-carbapenemase genes, aided by the introduction of CRAb from foreign countries. Healthcare professionals should remain aware of the risk of hospitalization in a high-risk country and the potential secondary transmission of CRAb to patients in countries with a low prevalence of this organism.

20 December 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
HBHetty Blaak
Hetty Blaak
SWSandra Witteveen
Sandra Witteveen
AHAngela de Haan
Angela de Haan
MSMarga G. van Santen-Verheuvel
Marga G. van Santen-Verheuvel
MKMerel A. Kemper
Merel A. Kemper
TGThe Dutch CPE Surveillance Study Group
The Dutch CPE Surveillance Study Group
Wastewater-based surveillance is gaining interest worldwide as a complementary tool informing human surveillance of pathogens, among which are antibiotic-resistant bacteria. The current study investigated whether CPE detected within the Dutch human CPE surveillance could be identified among isolates that were independently retrieved from Dutch wastewater. Whole genomes of 203 wastewater- and 1278 human-retrieved isolates were compared using whole-genome multilocus sequence typing (wgMLST), resistome, and plasmid analyses. Overall, 25 clusters (16 E. coli, 9 K. pneumoniae) with genetically highly related variants from both niches were detected. The maximum allelic difference between human- and wastewater-derived isolates in clusters was on average 0.51% (23/4503 alleles, E. coli) and 0.22% (11/4978 alleles K. pneumoniae). For seven clusters, in-depth plasmid analysis was performed, showing highly homologous (87–100%) carbapenemase-containing plasmids from human- and wastewater-retrieved isolates. Six clusters contained wastewater and human isolates that were spatiotemporally related. The sequence identity at chromosomal and plasmid level confirms the presence of human-associated CPE variants in wastewater. Ongoing comparisons between isolates from the national human CPE surveillance and wastewater surveillance will shed more light on the added value of wastewater-based surveillance for monitoring of CPE and other (emerging) antibiotic resistances.